Allergens, Allergy Testing, and Allergy Therapeutics
2023 AAAAI Annual Meeting - Virtual Content Available
The 2023 AAAAI Annual Meeting is available for virtual participation through December 31, 2023. Visit the Annual Meeting website to register and access the virtual content.
Sessions on Allergens, Allergy Testing, and Allergy Therapeutics include:
1206 Effects of Climate Change on Health: Practical Information and Strategies for Climate Change Communication
1527 Cannabis-Related Allergies: Approaches and Potential Management
1808 Interplay of the Microbiome, Viruses, Allergens and Biologics
2301 World Allergy Forum: New Treatments for Difficult to Treat Inflammatory Diseases – Biologics and Small Molecules
2306 Emerging Diagnostic and Monitoring Approaches in Eosinophilic Gastrointestinal Diseases (EGID)
2805 Managing Anaphylaxis to Allergy Injections: “Time is of the Essence”
3309 Advancing the Safety of Allergen Immunotherapy
4307 Climate Change, its Effects on Aeroallergens, and the Clinical Consequences
4713 Updates in Immunotherapy: Dosing, Cross Reactivity and Extract Stability
5403 Use of Sublingual Immunotherapy (SLIT) for Allergic Rhinitis and Conjuntivitis in the United States
5602 Novel Ways of Treating or Preventing Allergies and Asthma: Looking Down the Pipeline
5603 Mold Allergy: Current 'Growth' in Knowledge
5604 Allergy In-Vitro Diagnostics
5607 How Aerobiology Knowledge Could Improve Allergy Practice: From Microscope to Office Practice
Allergens, Allergy Testing, and Allergy Therapeutics Resources for Healthcare Providers
Allergy Skin Test and Immunotherapy Forms
Compounding Corner: Resources for USP Chapter 797 Standards for Physician In-Office Compounding of Allergen Extracts
Consultation and Referral Guidelines
AAAAI Statements and Practice Parameters reflect the most current guidance available from the AAAAI on clinical topics related to allergies, asthma and immunologic disease.
Allergens, Allergy Testing, and Allergy Therapeutics Resources include an overview, explanation of symptoms and diagnosis, treatment and management, an action plan, information for patients, and more.
Collaborate with Allergy Professionals
Interested in collaborating with fellow AAAAI members who share a particular interest in Allergy Education? The IRSO Interest Section is the community for AAAAI members interested in focusing and networking on the pathogenesis, prevalence, diagnosis and management of rhinitis, sinusitis and hypersensitivity ocular disorders. Topics covered include: allergy diagnostics and standardization, immunotherapy, diagnosis and treatment of rhinitis, sinusitis and ophthalmic conditions secondary to allergy.
To learn more about the work of this interest section, contact one of the leaders below:
Vice Chair: Tolly Epstein, MD MS FAAAAI
Secretary: Punita Ponda, MD FAAAAI
Staff Liaison: Cate O'Brien
Interested in aligning with IRSO?
Becoming part of the IRSO community network is as simple as linking to your AAAAI personal member profiles and updating your profile to reflect your primary membership as IRSO under the tab labeled Involvement.
Or, consider the work of the Immunotherapy, Allergen Standardization and Allergy Diagnostics Committee. Its purpose is to promote education concerning the diagnosis, assessment and treatment of allergies. NOTE: Interest Section Committees are open to all members of the AAAAI.